Research
-
Starting soon
June 2024 - February 2025
The effect of the density and distribution of panretinal photocoagulation (PRP) laser on driving visual fields in people with diabetes
-
Active
December 2023 - November 2024
Characterising the retina and subsequent damage in a model of Mucopolysaccharidosis Type IIIC
Characterisation of Retinal Phenotype in HGSNAT-deficient mice (Mucopolysaccharidosis Type IIIC)
-
Active
November 2023 - October 2024
Developing a Patient Reported Outcome Measure (PROM) for inflammatory eye disease and validation of a novel approach for PROM content identification
-
Completed
January 2023 - July 2023
Novel cell therapy approach to reduce IOP in glaucoma via nitric oxide production
-
Completed
May 2021 - December 2023
Characterisation of retinal development in a zebrafish model of Wolfram Syndrome
-
Active
November 2022 - September 2024
Addressing Barriers to Amblyopia Therapy
-
Active
December 2022 - May 2024
Inflammatory eye disease as a Canary in the Coal Mine for future autoimmune disease: combining genetic and other variables to enhance individual risk prediction
-
Completed
January 2023 - December 2023
Developing a new model to study drusen formation
Modelling drusen formation in retinal pigment epithelial cells and investigating drug candidates to slow the progression of AMD.
-
Active
June 2020 - October 2024
Understanding a molecular mechanism as a cause of retinitis pigmentosa
Exploring the molecular mechanism of a new cause of autosomal dominant retinitis pigmentosa and potential therapies.